Non-Invasive Treatment: Unlike surgical weight loss options, GLP-1 injections are non-invasive and require minimal downtime
Based on user experiences and clinical observations: First Month Initial weight loss begins Some patients report minor improvements in triglycerides Blood glucose stabilization typically begins 2-3 Months More substantial weight loss (often 5-10% of starting weight) Notable improvements in triglyceride levels LDL cholesterol typically begins showing measurable decreases 6 Months and Beyond Continued weight loss contributes to further cholesterol improvement Many patients report normalized cholesterol levels Some individuals may achieve sufficient improvement to reduce or eliminate statin therapy (only under medical supervision) Whats particularly interesting is that some patients report cholesterol improvements that occur faster than their weight loss would predict, suggesting GLP-1 medications may have direct effects on lipid metabolism beyond weight reduction
The stomach becomes too weak to effectively move food into the intestines, which slows down digestion
history of or active ischemic, hemorrhagic or anatomical neurovascular disease, including transient ischemic attack, cerebrovascular accident, arteriovenous malformation or brain aneurysm, peripheral vascular disease such as deep vein thrombosis/pulmonary embolism, chronic venous insufficiency, claudication or lymphedema
This combination helps regulate blood sugar levels and appetite